CH656801A5 - Medicaments contenant un derive du psoralene. - Google Patents

Medicaments contenant un derive du psoralene. Download PDF

Info

Publication number
CH656801A5
CH656801A5 CH2751/83A CH275183A CH656801A5 CH 656801 A5 CH656801 A5 CH 656801A5 CH 2751/83 A CH2751/83 A CH 2751/83A CH 275183 A CH275183 A CH 275183A CH 656801 A5 CH656801 A5 CH 656801A5
Authority
CH
Switzerland
Prior art keywords
methoxypsoralen
medicines
active substance
cells
contain
Prior art date
Application number
CH2751/83A
Other languages
English (en)
French (fr)
Inventor
Jean-Jacques Goupil
Original Assignee
Goupil Jean Jacques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goupil Jean Jacques filed Critical Goupil Jean Jacques
Publication of CH656801A5 publication Critical patent/CH656801A5/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37Coumarins, e.g. psoralen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CH2751/83A 1982-04-09 1983-05-19 Medicaments contenant un derive du psoralene. CH656801A5 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8206262A FR2524801B1 (fr) 1982-04-09 1982-04-09 Medicaments contenant un derive du psoralene
BE0/210731A BE896700A (fr) 1982-04-09 1983-05-09 Medicaments contenant un derive du psoralene.

Publications (1)

Publication Number Publication Date
CH656801A5 true CH656801A5 (fr) 1986-07-31

Family

ID=36782343

Family Applications (1)

Application Number Title Priority Date Filing Date
CH2751/83A CH656801A5 (fr) 1982-04-09 1983-05-19 Medicaments contenant un derive du psoralene.

Country Status (7)

Country Link
JP (1) JPH0653664B2 (ja)
AU (1) AU559029B2 (ja)
BE (1) BE896700A (ja)
CA (1) CA1205386A (ja)
CH (1) CH656801A5 (ja)
FR (1) FR2524801B1 (ja)
GB (1) GB2140686B (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9106365D0 (en) * 1991-03-26 1991-05-15 Bioglan Lab Ltd An emollient for use with ultraviolet light
FR2695036B1 (fr) * 1992-09-03 1994-10-28 Goupil Jean Jacques Huile contenant du 5-méthoxypsoralène à une concentration de 60 à 100 PPM et son utilisation pour le traitement du psoriasis.
US5556612A (en) * 1994-03-15 1996-09-17 The General Hospital Corporation Methods for phototherapeutic treatment of proliferative skin diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2406444A1 (fr) * 1977-10-21 1979-05-18 Goupil Jean Jacques Nouveau medicament contenant un derive du psoralene
LU80347A1 (fr) * 1977-10-21 1979-03-16 Goupil J 5-methoxy-psoralene comme nouveau medicament et procede de synthese

Also Published As

Publication number Publication date
CA1205386A (en) 1986-06-03
FR2524801A1 (fr) 1983-10-14
GB2140686A (en) 1984-12-05
AU559029B2 (en) 1987-02-19
GB2140686B (en) 1986-09-17
GB8315070D0 (en) 1983-07-06
JPH0653664B2 (ja) 1994-07-20
FR2524801B1 (fr) 1985-08-30
BE896700A (fr) 1983-09-01
AU1490583A (en) 1984-11-29
JPS59222413A (ja) 1984-12-14

Similar Documents

Publication Publication Date Title
CA2133429C (en) Topical administration of toremifene and its metabolites
ES2266554T3 (es) Composiciones farmaceuticas y cosmeticas que contienen aldehidos aromaticos que portan grupos oxi.
Walter et al. Psoriasis improved by psoralen plus black light
JP5389980B2 (ja) 手足症候群の治療のためのアロプリノールの使用
US7220438B2 (en) Pharmacological activities of Curcuma longa extracts
US6284797B1 (en) Topical treatment of pain and to promote healing
KR20040105706A (ko) 화학적 예방 활성을 나타내는 비스테로이드계 소염제를함유하는 국소 제형
US6733764B2 (en) Immunostimulator anti-cancer compounds and methods for their use in the treatment of cancer
Bruschi et al. Photodynamic therapy of psoriasis using photosensitizers of vegetable origin
US8609677B2 (en) Molecules for the photodynamic treatment of tumors and hyperplasias
WO2001021185A1 (es) Nuevas actividades farmacologicas de los extractos de curcuma longa
JPH0585523B2 (ja)
CH656801A5 (fr) Medicaments contenant un derive du psoralene.
JPH04500824A (ja) 光老化の作用を回復させるための皮膚の治療方法
US4970230A (en) Drugs containing a psoralene derivative
US10835584B2 (en) Systems for treating dermal inflammatory conditions
EP0586282A1 (fr) Compositions to piques comprenant du 5-méthoxypsoralène
JP7436471B2 (ja) 基底細胞癌および神経膠芽腫を治療する方法
US5200425A (en) Drugs containing a psoralene derivative
FR3031900A1 (fr) Triptolide et ses derives dans le traitement des tumeurs et pathologies pre-cancereuses cutanees
EP1967187B1 (fr) Composition à base de rutine et de L-lysine
WO2024013283A1 (fr) Nouveau regime posologique d'une composition comprenant de la brimonidine pour son utilisation dans la prevention et le traitement des dommages cutanes resultant d'un rayonnement
US20030083324A1 (en) Photosensitizing ointment
US20220218826A1 (en) Composition for topical use for photodynamic therapy
EP3746069A1 (en) Composition and use thereof against drugs induced phototoxicity

Legal Events

Date Code Title Description
PL Patent ceased